Managing Adverse Events Associated with Dinutuximab Beta Treatment in Patients with High-Risk Neuroblastoma: Practical Guidance

MLA

Onderzoek Beeld, et al. Managing Adverse Events Associated with Dinutuximab Beta Treatment in Patients with High-Risk Neuroblastoma: Practical Guidance. 2021. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1432118594&authtype=sso&custid=ns315887.

APA

Onderzoek Beeld, Barone, G., Barry, A., Bautista, F., Brichard, B., Defachelles, A.-S., Herd, F., Manzitti, C., Reinhardt, D., Rubio, P. M., Wieczorek, A., & van Noesel, M. M. (2021). Managing Adverse Events Associated with Dinutuximab Beta Treatment in Patients with High-Risk Neuroblastoma: Practical Guidance.

Chicago

Onderzoek Beeld, Giuseppe Barone, Ailish Barry, Francisco Bautista, Bénédicte Brichard, Anne-Sophie Defachelles, Fiona Herd, et al. 2021. “Managing Adverse Events Associated with Dinutuximab Beta Treatment in Patients with High-Risk Neuroblastoma: Practical Guidance.” http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1432118594&authtype=sso&custid=ns315887.